Park Ha Biological Techno... (PHH)
Park Ha Biological Technology Statistics
Share Statistics
Park Ha Biological Technology has 26.37M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 26.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 6.77K |
| FTD / Avg. Volume | 2.22% |
Short Selling Information
The latest short interest is 117.88K, so 0.45% of the outstanding shares have been sold short.
| Short Interest | 117.88K |
| Short % of Shares Out | 0.45% |
| Short % of Float | 1.61% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Park Ha Biological Technology's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Park Ha Biological Technology has an Enterprise Value (EV) of -476.92K.
| EV / Sales | -0.2 |
| EV / EBITDA | -0.58 |
| EV / EBIT | -0.5 |
| EV / FCF | -0.55 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.87 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 31.78% and Return on Invested Capital is 30.37%.
| Return on Equity | 31.78% |
| Return on Assets | 15.52% |
| Return on Invested Capital | 30.37% |
| Revenue Per Employee | $140.11K |
| Profits Per Employee | $28.15K |
| Employee Count | 17 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | 314.86K |
| Effective Tax Rate | 39.68% |
Stock Price Statistics
The stock price has increased by 31.18% in the last 52 weeks. The beta is -0.02, so Park Ha Biological Technology's price volatility has been lower than the market average.
| Beta | -0.02 |
| 52-Week Price Change | 31.18% |
| 50-Day Moving Average | 10.44 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 61.78 |
| Average Volume (20 Days) | 305.65K |
Income Statement
In the last 12 months, Park Ha Biological Technology had revenue of 2.38M and earned 478.56K in profits. Earnings per share was 0.02.
| Revenue | 2.38M |
| Gross Profit | 2.19M |
| Operating Income | 793.71K |
| Net Income | 478.56K |
| EBITDA | 816.4K |
| EBIT | 793.71K |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 547.5K in cash and 70.32K in debt, giving a net cash position of 477.18K.
| Cash & Cash Equivalents | 547.5K |
| Total Debt | 70.32K |
| Net Cash | 477.18K |
| Retained Earnings | 271.79K |
| Total Assets | 3.08M |
| Working Capital | 1.32M |
Cash Flow
In the last 12 months, operating cash flow was 960.47K and capital expenditures -85.57K, giving a free cash flow of 874.9K.
| Operating Cash Flow | 960.47K |
| Capital Expenditures | -85.57K |
| Free Cash Flow | 874.9K |
| FCF Per Share | 0.03 |
Margins
Gross margin is 91.8%, with operating and profit margins of 33.32% and 20.09%.
| Gross Margin | 91.8% |
| Operating Margin | 33.32% |
| Pretax Margin | 33.31% |
| Profit Margin | 20.09% |
| EBITDA Margin | 34.28% |
| EBIT Margin | 33.32% |
| FCF Margin | 36.73% |
Dividends & Yields
PHH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 182656.87% |
| FCF Yield | 333931.68% |
Analyst Forecast
Currently there are no analyst rating for PHH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 53.33 |
| Piotroski F-Score | 5 |